Neuromuscular Manifestations Clinical Trial
Official title:
Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT
After anesthesia is induced, 2 EMG TOFF devices will be placed on the patients arms, one on the right arm, the other on the left. There will be a randomization per dominant hand and nondominant hand for the placing of the devices. The devices are the Stimpod NMX450X and the Datex-Ohmeda E-NMT.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients (18 years old and above) - undergoing General Anaesthesia for noncardiac surgery requiring the use of a neuromuscular blocking agent. Exclusion Criteria: - Use of different types of neuromuscular blocking agents for the same patient within the same surgical procedure. - Known Neuromuscular diseases/syndromes judged to condition accurate neuromuscular monitoring. - Known acute or chronic hepatic disease. |
Country | Name | City | State |
---|---|---|---|
Belgium | UZ Brussel | Jette | Brussel |
Lead Sponsor | Collaborator |
---|---|
Universitair Ziekenhuis Brussel |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | TOF-ratio (percentage) | TOF = Train-of-four. TOF-ratio is the ratio of the fourth muscle response to the first one. This is used to assess neuromuscular transmission. TOF% indicates fade in non-depolarizing block. We are comparing the calculated TOF ratio of the stimpod NMX to the datex-ohmeda E-NMT | Up until 120 minutes | |
Secondary | TOF-count (absolute number) | TOF count is the actual number of detected muscle responses. The number that is used to calculate the percentage (TOF-ratio). When the TOF count drops below 4 responses, then the TOF% cannot be calculated. We are comparing the detected muscle responses of the stimpod NMX to the datex-ohmeda E-NMT | Up until 120 minutes. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT06381284 -
Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated Assessment
|
||
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Completed |
NCT02689544 -
Effects of Static Stretching and Dynamic in Flexibility and Performance: Blind and Randomized Clinical Trial
|
N/A | |
Completed |
NCT05738200 -
Nordic Hamstring Exercise After ACL Reconstruction Reconstruction
|
N/A | |
Completed |
NCT03211390 -
Using Telemedicine to Improve Spasticity Diagnosis Rates
|
||
Completed |
NCT03209960 -
Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
|
||
Completed |
NCT03250988 -
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
|
||
Active, not recruiting |
NCT05156320 -
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
|
Phase 3 | |
Completed |
NCT03221439 -
Cognitive Functional Therapy for Chronic Low Back Pain
|
N/A | |
Completed |
NCT03921528 -
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
|
Phase 2 | |
Active, not recruiting |
NCT05626855 -
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
|
Phase 3 | |
Recruiting |
NCT05810272 -
Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
|
N/A |